Voloridge Investment Management
PACB icon

Voloridge Investment Management’s Pacific Biosciences PACB Stock Holding History

Voloridge Investment Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69,114
Closed -$259K – 1335
2024
Q1 		$259K Buy
+69,114
New +$405K ﹤0.01% 1093
2023
Q4 		– Sell
-386,690
Closed -$3.23M – 1391
2023
Q3 		$3.23M Sell
386,690
-563,774
-59% -$6.44M 0.02% 788
2023
Q2 		$12.6M Sell
950,464
-764,942
-45% -$9.3M 0.06% 402
2023
Q1 		$19.9M Buy
1,715,406
+1,523,472
+794% +$15.1M 0.1% 281
2022
Q4 		$1.57M Buy
+191,934
New +$1.65M 0.01% 1033
2022
Q3 		– Sell
-220,926
Closed -$976K – 1570
2022
Q2 		$976K Sell
220,926
-625,254
-74% -$3.8M 0.01% 1197
2022
Q1 		$7.7M Buy
+846,180
New +$9.74M 0.04% 494
2020
Q4 		– Sell
-539,897
Closed -$5.33M – 1505
2020
Q3 		$5.33M Buy
+539,897
New +$3.11M 0.04% 429
2019
Q3 		– Sell
-12,873
Closed -$78K – 1185
2019
Q2 		$78K Sell
12,873
-5,603
-30% -$39.3K ﹤0.01% 720
2019
Q1 		$134K Buy
+18,476
New +$134K ﹤0.01% 905

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management's PACB Position: Q2 2024 in Review

Voloridge Investment Management sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 69,114 shares — an estimated $259K sold.

Voloridge Investment Management first reported a position in PACB in Q1 2019 and held it in 10 quarters. The position peaked at $19.9M in Q1 2023. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Voloridge Investment Management reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 69,114 Pacific Biosciences shares in Q2 2024, an estimated $259K.
  • Voloridge Investment Management first reported a position in Pacific Biosciences in Q1 2019 and held it in 10 quarters.
  • Voloridge Investment Management's Pacific Biosciences position peaked at $19.9M in Q1 2023.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Voloridge Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.